Literature DB >> 29251177

Co-expression of RelA/p65 and ACTN4 induces apoptosis in non-small lung carcinoma cells.

Ekaterina Lomert1, Lidia Turoverova1, Daria Kriger1, Nikolai D Aksenov1, Alina D Nikotina1, Alexey Petukhov1,2, Alexey G Mittenberg1, Nikolai V Panyushev1, Mikhail Khotin1, Kirill Volkov3, Nikolai A Barlev1, Dmitri Tentler1.   

Abstract

Alpha-actinin 4 (ACTN4) is an actin-binding protein of the spectrin superfamily. ACTN4 is found both in the cytoplasm and nucleus of eukaryotic cells. The main function of cytoplasmic ACTN4 is stabilization of actin filaments and their binding to focal contacts. Nuclear ACTN4 takes part in the regulation of gene expression following by activation of certain transcription factors, but the mechanisms of regulation are not completely understood. Our previous studies have demonstrated the interaction of ACTN4 with the RelA/p65 subunit of NF-kappaB factor and the effect on its transcriptional activity in A431 and HEK293T cells. In the present work, we investigated changes in the composition of nuclear ACTN4-interacting proteins in non-small cell lung cancer cells H1299 upon stable RELA overexpression. We showed that ACTN4 was present in the nuclei of H1299 cells, regardless of the RELA expression level. The presence of ectopic RelA/p65 in H1299 cells increased the number of proteins interacting with nuclear ACTN4. Stable expression of RELA in these cells suppressed cell proliferation, which was further affected by simultaneous ACTN4 overexpression. We detected no significant effect on cell cycle but the apoptosis rate was increased in cells with a double RELA/ACTN4 overexpression. Interestingly, when expressed individually ACTN4 promoted proliferation of lung cancer cells. Furthermore, the bioinformatics analysis of gene expression in lung cancer patients suggested that overexpression of ACTN4 correlated with poor survival prognosis. We hypothesize that the effect of RELA on proliferation and apoptosis of H1299 cells can be mediated via affecting the interactome of ACTN4.

Entities:  

Keywords:  ACTN4; H1299; RelA/p65; apoptosis; cell proliferation; lung adenocarcinoma; mass spectrometry

Mesh:

Substances:

Year:  2018        PMID: 29251177      PMCID: PMC5969568          DOI: 10.1080/15384101.2017.1417709

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  42 in total

1.  Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.

Authors:  J M Kaplan; S H Kim; K N North; H Rennke; L A Correia; H Q Tong; B J Mathis; J C Rodríguez-Pérez; P G Allen; A H Beggs; M R Pollak
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

2.  E-cadherin regulates the association between beta-catenin and actinin-4.

Authors:  Yasuharu Hayashida; Kazufumi Honda; Masashi Idogawa; Yoshinori Ino; Masaya Ono; Akihiko Tsuchida; Tatsuya Aoki; Setsuo Hirohashi; Tesshi Yamada
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

3.  In-gel digestion for mass spectrometric characterization of proteins and proteomes.

Authors:  Andrej Shevchenko; Henrik Tomas; Jan Havlis; Jesper V Olsen; Matthias Mann
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  Functional analysis of HSPA1A and HSPA8 in parturition.

Authors:  Junnan Geng; Huanan Li; Cong Huang; Jin Chai; Rong Zheng; Fenge Li; Siwen Jiang
Journal:  Biochem Biophys Res Commun       Date:  2016-12-23       Impact factor: 3.575

5.  Txk, a member of the non-receptor tyrosine kinase of the Tec family, forms a complex with poly(ADP-ribose) polymerase 1 and elongation factor 1alpha and regulates interferon-gamma gene transcription in Th1 cells.

Authors:  T Maruyama; K Nara; H Yoshikawa; N Suzuki
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

6.  Mass spectrometry analysis of the native protein complex containing actinin-4 in prostate cancer cells.

Authors:  Tomohiko Hara; Kazufumi Honda; Miki Shitashige; Masaya Ono; Hideyasu Matsuyama; Katsusuke Naito; Setsuo Hirohashi; Tesshi Yamada
Journal:  Mol Cell Proteomics       Date:  2006-12-06       Impact factor: 5.911

7.  BioProfiling.de: analytical web portal for high-throughput cell biology.

Authors:  Alexey V Antonov
Journal:  Nucleic Acids Res       Date:  2011-05-23       Impact factor: 16.971

8.  Interaction of Cx43 with Hsc70 regulates G1/S transition through CDK inhibitor p27.

Authors:  Hitoshi Hino; Ping Dai; Tatsushi Yoshida; Tomoya Hatakeyama; Yoshinori Harada; Eigo Otsuji; Tsukasa Okuda; Tetsuro Takamatsu
Journal:  Sci Rep       Date:  2015-10-20       Impact factor: 4.379

9.  The biological role of actinin-4 (ACTN4) in malignant phenotypes of cancer.

Authors:  Kazufumi Honda
Journal:  Cell Biosci       Date:  2015-08-18       Impact factor: 7.133

10.  Mutant p53 regulates Dicer through p63-dependent and -independent mechanisms to promote an invasive phenotype.

Authors:  Patricia A J Muller; Antonio G Trinidad; Patrick T Caswell; Jim C Norman; Karen H Vousden
Journal:  J Biol Chem       Date:  2013-11-12       Impact factor: 5.157

View more
  8 in total

1.  Epigallocatechin Gallate Induces the Demethylation of Actinin Alpha 4 to Inhibit Diabetic Nephropathy Renal Fibrosis via the NF-KB Signaling Pathway In Vitro.

Authors:  Chunling He; Dong Wang; Ruoling Wang; Yongli Huang; Xin Huang; ShuMin Shen; Jun Lv; Mingcai Wu
Journal:  Dose Response       Date:  2022-06-10       Impact factor: 2.623

2.  ACTN4 Promotes the Proliferation, Migration, Metastasis of Osteosarcoma and Enhances its Invasive Ability through the NF-κB Pathway.

Authors:  Qingshan Huang; Xiaodong Li; Zhen Huang; Fengqiang Yu; Xinwen Wang; Shenglin Wang; Zhizhen He; Jianhua Lin
Journal:  Pathol Oncol Res       Date:  2019-03-16       Impact factor: 3.201

3.  DriverDBv3: a multi-omics database for cancer driver gene research.

Authors:  Shu-Hsuan Liu; Pei-Chun Shen; Chen-Yang Chen; An-Ni Hsu; Yi-Chun Cho; Yo-Liang Lai; Fang-Hsin Chen; Chia-Yang Li; Shu-Chi Wang; Ming Chen; I-Fang Chung; Wei-Chung Cheng
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

Review 4.  Role of ACTN4 in Tumorigenesis, Metastasis, and EMT.

Authors:  Dmitri Tentler; Ekaterina Lomert; Ksenia Novitskaya; Nikolai A Barlev
Journal:  Cells       Date:  2019-11-13       Impact factor: 6.600

5.  Exploring the mechanism of aidi injection for lung cancer by network pharmacology approach and molecular docking validation.

Authors:  Zhenjie Zhuang; Tong Lin; Zhanhua Liu; Lizhu Lin; Lixia Luo; Weixin Zhou; Junmao Wen; Haifu Huang
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

6.  Gene model-related m6A expression levels predict the risk of preeclampsia.

Authors:  Yiwei Li; Can Chen; Mengyuan Diao; Yanli Wei; Ying Zhu; Wei Hu
Journal:  BMC Med Genomics       Date:  2022-05-05       Impact factor: 3.622

7.  Ceramide Pathway Regulators Predict Clinical Prognostic Risk and Affect the Tumor Immune Microenvironment in Lung Adenocarcinoma.

Authors:  Yuan Zhang; Jianbo Chen; Yunan Zhao; Lihong Weng; Yiquan Xu
Journal:  Front Oncol       Date:  2020-10-27       Impact factor: 6.244

8.  A Novel Risk Model Based on Autophagy Pathway Related Genes for Survival Prediction in Lung Adenocarcinoma.

Authors:  Fan Zhang; Suzhen Xie; Zhenyu Zhang; Huanhuan Zhao; Zijun Zhao; Haiying Sun; Jiao Zheng
Journal:  Med Sci Monit       Date:  2020-09-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.